Credit: Tobias Wuestefeld / illustratoren.de Product launches Our continued commitment to and significant investment in R&D have once again enabled BD to launch new and innovative products and technologies. Here are some that launched in 2021. BD ® AbSeq Immune Discovery Panel: a tool that enables researchers to uncover up to 30 immune markers in a single experiment, offering convenience, reliability and flexibility as both a multiomics-enabled and cost-efficient tool to aid in immune research and discovery. BD COR™ Molecular Diagnostic System: a new, fully automated, high-throughput molecular diagnostic platform that uses robotics and sample management software algorithms to set a new standard in automation for infectious disease molecular testing in core and other centralized laboratories in the U.S. This system allows the BD Onclarity™ HPV Assay with extended genotyping for the BD COR™ System to be made available to the high-throughput labs that process the majority of cervical cancer screening specimens in the U.S. BD FACSymphony™ A1 Cell Analyzer: a new fluorescence-activated cell analyzer that offers advanced research capabilities in a compact design, and helps improve access to instrumentation for complex scientific research for laboratories of all sizes. BD Kiestra™ Lab Automation System: U.S. launch of Urine Culture Application for use with the BD Kiestra™ lab automation, incubation and imaging system that can transform the way microbiology labs approach urine culture analysis. The application was designed using artificial intelligence. BD Pristine™ Long-Term Hemodialysis Catheter: a differentiated product that received 510(k) clearance in 2021, adding to the company’s diversified portfolio to support clinicians who care for end-stage kidney disease patients requiring hemodialysis. BD Onclarity™ HPV Assay CE marked for Self-Collection: an industry-first product that allows laboratories and facilities to process at-home, self-collected vaginal samples. BD Surgiphor™ Surgical Irrigation System: an industry-first, ready-to-use, iodine-based surgical irrigation system that mechanically loosens and removes wound debris. New BD innovation in flow Cytometry BD was profiled in a cover story of the January issue of Science magazine, demonstrating landmark advancement in flow Cytometry technology with potential to transform a wide range of disciplines, from immunology and genomics research to cell-based therapeutics. FY19 FY20 FY21 Research and development expense (in millions) $ 1,062 $1,096 $ 1,399 % of revenues 6.1% 6.4% 6.6% 14 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction